| 英文别名 |
Imp. J (EP): 16 ,17-[(1RS)-Butylidenebis(oxy)]-9 -bromo-11 ,21-dihydroxypregna-1,4-diene-3,20-dione;9α-Bromobudesonide;Budesonide EP Impurity J;CID 145714347;Budesonide EP Imp J;Budesonide EP Impurity J (Mixture of Diastereomers);9alpha-Bromobudesonide;Budesonide Impurity J;16α,17-[(1RS)-butylidenebis(oxy)]-9α-bromo-11β,21-dihydroxypregna-1,4-diene-3,20-dione;Budesonide Impurity J (Mixture of Diastereomers);16alpha,17-[(1RS)-Butylidenebis(oxy)]-9alpha-bromo-11beta,21-dihydroxypregna-1,4-diene-3,20-dione;313474-59-8;Pregna-1,4-diene-3,20-dione, 9-bromo-16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11beta,16alpha)-;UNII-D7DSY2P2HX;BUDESONIDE IMPURITY J [EP IMPURITY];(1S,2S,4R,8S,9S,11S,12R,13S)-12-Bromo-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one;PREGNA-1,4-DIENE-3,20-DIONE, 9-BROMO-16,17-(BUTYLIDENEBIS(OXY))-11,21-DIHYDROXY-, (11.BETA.,16.ALPHA.)-;9a-Bromobudesonide;Budesonide impurity J [EP];CS-0166435;16.ALPHA.,17-((1RS)-BUTYLIDENEBIS(OXY))-9.ALPHA.-BROMO-11.BETA.,21-DIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE;9.ALPHA.-BROMOBUDESONIDE;16alpha,17-((1RS)-Butylidenebis(oxy))-9alpha-bromo-11beta,21-dihydroxypregna-1,4-diene-3,20-dione;D7DSY2P2HX;Budesonide Imp. J (EP); 16alpha,17-[(1RS)-Butylidene-bis(oxy)]-9alpha-bromo-11beta,21-dihydroxypregna-1,4-diene-3,20-dione; (11beta,16alpha)-9-bromo-16,17-[butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione; Budesonide Impurity J;G91083;(6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-6b-bromo-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one (Budesonide Impurity |